AAAAAA
Results:
1-20
|
Results: 20
Authors:
Cao, B
Su, YL
Oskarsson, M
Zhao, P
Kort, EJ
Fisher, RJ
Wang, LM
Vande Woude, GF
Citation: B. Cao et al., Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models, P NAS US, 98(13), 2001, pp. 7443-7448
Authors:
Xiao, GH
Jeffers, M
Bellacosa, A
Mitsuuchi, Y
Vande Woude, GF
Testa, JR
Citation: Gh. Xiao et al., Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways, P NAS US, 98(1), 2001, pp. 247-252
Authors:
Vousden, KH
Vande Woude, GF
Citation: Kh. Vousden et Gf. Vande Woude, The ins and outs of p53, NAT CELL BI, 2(10), 2000, pp. E178-E180
Authors:
Furge, KA
Zhang, YW
Vande Woude, GF
Citation: Ka. Furge et al., Met receptor tyrosine kinase: enhanced signaling through adapter proteins, ONCOGENE, 19(49), 2000, pp. 5582-5589
Authors:
Lee, JH
Han, SU
Cho, H
Jennings, B
Gerrard, B
Dean, M
Schmidt, L
Zbar, B
Vande Woude, GF
Citation: Jh. Lee et al., A novel germ line juxtamembrane Met mutation in human gastric cancer, ONCOGENE, 19(43), 2000, pp. 4947-4953
Authors:
Firon, M
Shaharabany, M
Altstock, RT
Horev, J
Abramovici, A
Resau, JH
Vande Woude, GF
Tsarfaty, I
Citation: M. Firon et al., Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells, ONCOGENE, 19(20), 2000, pp. 2386-2397
Authors:
Taylor, GA
Collazo, CM
Yap, GS
Nguyen, K
Gregorio, TA
Taylor, LS
Eagleson, B
Secrest, L
Southon, EA
Reid, SW
Tessarollo, L
Bray, M
McVicar, DW
Komschlies, KL
Young, HA
Biron, CA
Sher, A
Vande Woude, GF
Citation: Ga. Taylor et al., Pathogen-specific loss of host resistance in mice lacking the IFN-gamma-inducible gene IGTP, P NAS US, 97(2), 2000, pp. 751-755
Authors:
Taylor, GA
Hudson, E
Resau, JH
Vande Woude, GF
Citation: Ga. Taylor et al., Regulation of P311 expression by Met-hepatocyte growth factor/scatter factor and the ubiquitin/proteasome system, J BIOL CHEM, 275(6), 2000, pp. 4215-4219
Authors:
Webb, CP
Hose, CD
Koochekpour, S
Jeffers, M
Oskarsson, M
Sausville, E
Monks, A
Vande Woude, GF
Citation: Cp. Webb et al., The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-Met-urokinase plasminogen activator-plasmin proteolytic network, CANCER RES, 60(2), 2000, pp. 342-349
Authors:
Beilmann, M
Vande Woude, GF
Dienes, HP
Schirmacher, P
Citation: M. Beilmann et al., Hepatocyte growth factor-stimulated invasiveness of monocytes, BLOOD, 95(12), 2000, pp. 3964-3969
Authors:
Koo, HM
Gray-Goodrich, M
Kohlhagen, G
McWilliams, MJ
Jeffers, M
Vaigro-Wolff, A
Alvord, WG
Monks, A
Paull, KD
Pommier, Y
Vande Woude, GF
Citation: Hm. Koo et al., The ras oncogene-mediated sensitization of human cells to topoisomerase IIinhibitor-induced apoptosis, J NAT CANC, 91(3), 1999, pp. 236-244
Authors:
Koo, MM
Vande Woude, GF
Citation: Mm. Koo et Gf. Vande Woude, The ras oncogene mediated sensitization of human cells to topoisomerase IIinhibitor-induced apoptosis, J NAT CANC, 91(22), 1999, pp. 1969-1969
Authors:
Duesbery, NS
Vande Woude, GF
Citation: Ns. Duesbery et Gf. Vande Woude, Anthrax toxins, CELL MOL L, 55(12), 1999, pp. 1599-1609
Authors:
Duesbery, NS
Vande Woude, GF
Citation: Ns. Duesbery et Gf. Vande Woude, Anthrax lethal factor causes proteolytic inactivation of mitogen-activatedprotein kinase kinase, J APPL MICR, 87(2), 1999, pp. 289-293
Authors:
Jeffers, M
Vande Woude, GF
Citation: M. Jeffers et Gf. Vande Woude, Activating mutations in the Met receptor overcome the requirement for autophosphorylation of tyrosines crucial for wild type signaling, ONCOGENE, 18(36), 1999, pp. 5120-5125
Authors:
Murakami, MS
Copeland, TD
Vande Woude, GF
Citation: Ms. Murakami et al., Mos positively regulates Xe-Wee1 to lengthen the first mitotic cell cycle of Xenopus, GENE DEV, 13(5), 1999, pp. 620-631
Authors:
Tsarfaty, I
Alvord, WG
Resau, JH
Altstock, RT
Lidereau, R
Bieche, I
Bertrand, F
Horev, J
Klabansky, RL
Keydar, I
Vande Woude, GF
Citation: I. Tsarfaty et al., Alteration of Met protooncogene product expression and prognosis in breastcarcinomas, ANAL QUAN C, 21(5), 1999, pp. 397-408
Authors:
Koochekpour, S
Jeffers, M
Wang, PH
Gong, CN
Taylor, GA
Roessler, LM
Stearman, R
Vasselli, JR
Stetler-Stevenson, WG
Kaelin, WG
Linehan, WM
Klausner, RD
Gnarra, JR
Vande Woude, GF
Citation: S. Koochekpour et al., The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells, MOL CELL B, 19(9), 1999, pp. 5902-5912
Authors:
Ried, S
Jager, C
Jeffers, M
Vande Woude, GF
Graeff, H
Schmitt, M
Lengyel, E
Citation: S. Ried et al., Activation mechanisms of the urokinase-type plasminogen activator promoterby hepatocyte growth factor scatter factor, J BIOL CHEM, 274(23), 1999, pp. 16377-16386
Authors:
Duesbery, NS
Vande Woude, GF
Citation: Ns. Duesbery et Gf. Vande Woude, Cytoplasmic control of nuclear behavior during meiotic maturation of frog oocytes, BIO CELL, 90(6-7), 1998, pp. 461-466
Risultati:
1-20
|